Global Durvalumab Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Durvalumab is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period. The research provides insights for the global Durvalumab market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Durvalumab industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Durvalumab Market Segmentations:

    By Players:

    • Medimmune (AstraZeneca)

    By Types:

    • 24mL Injection

    • 10mL Injection

    By End-User:

    • Locally Advanced Urothelial Carcinoma

    • Metastatic Urothelial Carcinoma

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Durvalumab Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Durvalumab Market Size and Growth Rate of 24mL Injection from 2014 to 2026

      • 1.3.2 Global Durvalumab Market Size and Growth Rate of 10mL Injection from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2014 to 2026

      • 1.4.2 Global Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2014 to 2026

      • 1.4.3 Global Durvalumab Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Durvalumab Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Durvalumab Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Durvalumab Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Durvalumab Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Durvalumab Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Durvalumab Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Durvalumab by Major Types

      • 3.4.1 Durvalumab Market Size and Growth Rate of 24mL Injection

      • 3.4.2 Durvalumab Market Size and Growth Rate of 10mL Injection

    4 Segmentation of Durvalumab Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Durvalumab by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Durvalumab in Locally Advanced Urothelial Carcinoma

      • 4.4.2 Market Size and Growth Rate of Durvalumab in Metastatic Urothelial Carcinoma

      • 4.4.3 Market Size and Growth Rate of Durvalumab in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Durvalumab Production Analysis by Major Regions

    • 5.2 Global Durvalumab Consumption Analysis by Major Regions

    • 5.3 Global Durvalumab Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Durvalumab Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Durvalumab Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Durvalumab Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Durvalumab Production, Import, Consumption and Export Analysis

    6 Product Commodity of Durvalumab Market in Major Countries

    • 6.1 Top 5 Export Countries in Durvalumab market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Durvalumab market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Durvalumab market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Durvalumab market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Durvalumab market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Durvalumab market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Durvalumab Landscape Analysis

    • 7.1 North America Durvalumab Landscape Analysis by Major Types

    • 7.2 North America Durvalumab Landscape Analysis by Major End-Users

    • 7.3 North America Durvalumab Landscape Analysis by Major Countries

      • 7.3.1 United States Durvalumab Market Volume and Growth Rate

      • 7.3.2 Canada Durvalumab Market Volume and Growth Rate

      • 7.3.3 Mexico Durvalumab Market Volume and Growth Rate

    8 Europe Durvalumab Landscape Analysis

    • 8.1 Europe Durvalumab Landscape Analysis by Major Types

    • 8.2 Europe Durvalumab Landscape Analysis by Major End-Users

    • 8.3 Europe Durvalumab Landscape Analysis by Major Countries

      • 8.3.1 Germany Durvalumab Market Volume and Growth Rate

      • 8.3.2 UK Durvalumab Market Volume and Growth Rate

      • 8.3.3 France Durvalumab Market Volume and Growth Rate

      • 8.3.4 Italy Durvalumab Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Durvalumab Market Volume and Growth Rate

      • 8.3.6 Spain Durvalumab Market Volume and Growth Rate

      • 8.3.7 Belgium Durvalumab Market Volume and Growth Rate

      • 8.3.8 Poland Durvalumab Market Volume and Growth Rate

      • 8.3.9 Russia Durvalumab Market Volume and Growth Rate

      • 8.3.10 Turkey Durvalumab Market Volume and Growth Rate

    9 Asia Pacific Durvalumab Landscape Analysis

    • 9.1 Asia Pacific Durvalumab Landscape Analysis by Major Types

    • 9.2 Asia Pacific Durvalumab Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Durvalumab Landscape Analysis by Major Countries

      • 9.3.1 China Durvalumab Market Volume and Growth Rate

      • 9.3.2 Japan Durvalumab Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Durvalumab Market Volume and Growth Rate

      • 9.3.4 India Durvalumab Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Durvalumab Market Volume and Growth Rate

      • 9.3.6 South Korea Durvalumab Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Durvalumab Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Durvalumab Market Volume and Growth Rate

      • 10.3.2 Brazil Durvalumab Market Volume and Growth Rate

      • 10.3.3 Nigeria Durvalumab Market Volume and Growth Rate

      • 10.3.4 South Africa Durvalumab Market Volume and Growth Rate 

      • 10.3.5 Argentina Durvalumab Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Medimmune (AstraZeneca)

      • 11.1.1 Medimmune (AstraZeneca) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 85 Figures and 197 Tables)

    • Figure Product Picture

    • Figure Durvalumab Market Size and Growth Rate of 24mL Injection from 2014 to 2026

    • Figure Durvalumab Market Size and Growth Rate of 10mL Injection from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2014 to 2026

    • Figure Global Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2014 to 2026

    • Figure Global Durvalumab Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Durvalumab Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Durvalumab

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Durvalumab by Different Types from 2014 to 2026

    • Table Consumption Share of Durvalumab by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of 24mL Injection

    • Figure Market Size and Growth Rate of 10mL Injection

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Durvalumab by Different End-Users from 2014 to 2026

    • Table Consumption Share of Durvalumab by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma

    • Figure Market Size and Growth Rate of Metastatic Urothelial Carcinoma

    • Figure Market Size and Growth Rate of Other

    • Table Global Durvalumab Production by Major Regions

    • Table Global Durvalumab Production Share by Major Regions

    • Figure Global Durvalumab Production Share by Major Regions in 2014

    • Figure Global Durvalumab Production Share by Major Regions in 2018

    • Figure Global Durvalumab Production Share by Major Regions in 2026

    • Table Global Durvalumab Consumption by Major Regions

    • Table Global Durvalumab Consumption Share by Major Regions

    • Figure Global Durvalumab Consumption Share by Major Regions in 2014

    • Figure Global Durvalumab Consumption Share by Major Regions in 2018

    • Figure Global Durvalumab Consumption Share by Major Regions in 2026

    • Table North America Durvalumab Production, Import, Consumption and Export Analysis

    • Table Europe Durvalumab Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Durvalumab Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Durvalumab Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Durvalumab market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Durvalumab market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Durvalumab market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Durvalumab market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Durvalumab Consumption by Types from 2014 to 2026

    • Table North America Durvalumab Consumption Share by Types from 2014 to 2026

    • Figure North America Durvalumab Consumption Share by Types in 2014

    • Figure North America Durvalumab Consumption Share by Types in 2018

    • Figure North America Durvalumab Consumption Share by Types in 2026

    • Table North America Durvalumab Consumption by End-Users from 2014 to 2026

    • Table North America Durvalumab Consumption Share by End-Users from 2014 to 2026

    • Figure North America Durvalumab Consumption Share by End-Users in 2014

    • Figure North America Durvalumab Consumption Share by End-Users in 2018

    • Figure North America Durvalumab Consumption Share by End-Users in 2026

    • Table North America Durvalumab Consumption by Major Countries from 2014 to 2026

    • Table North America Durvalumab Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Durvalumab Consumption Share by Major Countries in 2014

    • Figure North America Durvalumab Consumption Share by Major Countries in 2018

    • Figure North America Durvalumab Consumption Share by Major Countries in 2026

    • Figure United States Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Durvalumab Consumption by Types from 2014 to 2026

    • Table Europe Durvalumab Consumption Share by Types from 2014 to 2026

    • Figure Europe Durvalumab Consumption Share by Types in 2014

    • Figure Europe Durvalumab Consumption Share by Types in 2018

    • Figure Europe Durvalumab Consumption Share by Types in 2026

    • Table Europe Durvalumab Consumption by End-Users from 2014 to 2026

    • Table Europe Durvalumab Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Durvalumab Consumption Share by End-Users in 2014

    • Figure Europe Durvalumab Consumption Share by End-Users in 2018

    • Figure Europe Durvalumab Consumption Share by End-Users in 2026

    • Table Europe Durvalumab Consumption by Major Countries from 2014 to 2026

    • Table Europe Durvalumab Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Durvalumab Consumption Share by Major Countries in 2014

    • Figure Europe Durvalumab Consumption Share by Major Countries in 2018

    • Figure Europe Durvalumab Consumption Share by Major Countries in 2026

    • Figure Germany Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure France Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Durvalumab Consumption by Types from 2014 to 2026

    • Table Asia Pacific Durvalumab Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Durvalumab Consumption Share by Types in 2014

    • Figure Asia Pacific Durvalumab Consumption Share by Types in 2018

    • Figure Asia Pacific Durvalumab Consumption Share by Types in 2026

    • Table Asia Pacific Durvalumab Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Durvalumab Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2014

    • Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2018

    • Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2026

    • Table Asia Pacific Durvalumab Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Durvalumab Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2026

    • Figure China Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandDurvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure India Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2026

    • Figure GCC Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Durvalumab Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Medimmune (AstraZeneca)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune (AstraZeneca)

    • Figure Sales and Growth Rate Analysis of Medimmune (AstraZeneca)

    • Figure Revenue and Market Share Analysis of Medimmune (AstraZeneca)

    • Table Product and Service Introduction of Medimmune (AstraZeneca)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.